Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Grapefruit juice prolongs patients’ QT interval

A high intake of grapefruit juice—and other dietary flavonoids found in fruits, vegetables, tea and wine—could correspond to QT interval prolongation in healthy individuals and those with heart disease, leaving them vulnerable to serious arrhythmias like torsades-de-pointes.

Early gastric bypass improves odds of diabetes remission in teens

Type 2 diabetes patients who undergo gastric bypass surgery as teenagers are more likely to achieve remission of their diabetes and hypertension in adulthood than adults who attempt the same procedure years later, according to a study funded by the National Institutes of Health.

Thumbnail

T-cells in arterial plaque could signal stroke risk

Researchers have linked a specific type of immune cell found in arterial plaque to increased probability of a stroke or mini-stroke.  

Thumbnail

FDA approves 1st anticoagulant for use in pediatric patients

Fragmin (dalteparin sodium), a type of heparin that works as an anticoagulant, was approved by the FDA May 16 to treat symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and up.

Thumbnail

ICDs are underused in clinical practice—especially in women and minorities

A trio of studies presented at the Heart Rhythm Society’s 40th annual scientific sessions earlier this month highlight significant disparities in patient access to implantable cardiac devices—particularly in women and black patients.

Thumbnail

More than ⅓ of statin patients fail to achieve healthy LDL-C

More than one-third of statin patients still fail to reach healthy LDL-cholesterol levels a year and a half after initiating treatment, leaving them vulnerable to adverse CV events and thousands of dollars in medical bills, according to a report in the Journal of Managed Care & Specialty Pharmacy.

Thumbnail

Arthritic pain reliever glucosamine cuts risk of CVD death by 22%

A dietary supplement commonly used to relieve osteoarthritis and joint pain may also double as a cardioprotector, Tulane University researchers reported in The BMJ May 14.

Thumbnail

Azithromycin ‘Z-packs’ tied to potentially fatal arrhythmia

The FDA is updating azithromycin drug labels to reflect evidence that the medication can contribute to a rare heart rhythm abnormality known as torsades de pointes.